Replies to post #423212 on Anavex Life Sciences Corp (AVXL)

[attilathehunt]

CHECK THIS OUT...

Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars
BENZINGA 10:18 AM ET 7/17/2023
Symbol Last Price Change
ALNY 213.24down +16.14 (+8.1887%)
REGN 725.23up +6.71 (+0.9339%)
QUOTES AS OF 10:55:10 AM ET 07/17/2023

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) announced updated interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP for Alzheimer's disease and cerebral amyloid angiopathy (CAA).

ALN-APP is an investigational RNAi therapeutic to demonstrate gene silencing in the human brain under development in collaboration with Regeneron